APH vs EUDAW · P/E 40, rev $23.09B vs rev $9.8M
Amphenol Corporation (APH) versus EUDA Health Holdings Limited (EUDAW) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
EUDA Health Holdings Limited (EUDAW) common stock listed on US.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported EUDAW revenue for 2022-12-31 was $9.8M. Net income was -$24.9M. Revenue was down 6.7% from 2021-12-31 to 2022-12-31. EUDAW currently screens at market cap $0.
APH currently screens at market cap $170.77B and trailing P/E 39.9. EUDAW currently screens at market cap $0.
Not investment advice. Open the APH and EUDAW stock pages for the full models.
Not investment advice.